Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.39 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.39 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.39 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.39 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.39 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.39 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.38 |
| ▸ | RRM1 | P23921 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2505238 | 1.00 | FFAR1 (0.43) | FFAR1KMT2AMEN1CHRM4PSEN1 | |
| SCHEMBL2505640 | 0.85 | PSEN1 (0.44) | FFAR1KMT2AMEN1PSEN1PSEN2 | |
| SCHEMBL2505243 | 0.85 | PSEN1 (0.44) | FFAR1KMT2AMEN1PSEN1PSEN2 | |
| SCHEMBL3658273 | 0.81 | KMT2A (0.47) | FFAR1KMT2AMEN1SMN1; SMN2KAT6A | |
| SCHEMBL3658813 | 0.81 | KMT2A (0.47) | FFAR1KMT2AMEN1SMN1; SMN2KAT6A | |
| SCHEMBL2505230 | 0.79 | FFAR1 (0.42) | FFAR1KMT2AMEN1GPR34ALOX5 | |
| SCHEMBL2499334 | 0.79 | FFAR1 (0.42) | FFAR1KMT2AMEN1GPR34ALOX5 | |
| SCHEMBL2495828 | 0.79 | HCAR1 (0.35) | FFAR1 | |
| SCHEMBL2503184 | 0.79 | HCAR1 (0.35) | FFAR1 | |
| SCHEMBL27830838 | 0.79 | HCAR1 (0.35) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030354-B2 | 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes | AMGEN INC. (US) | 2011-10-04 | — | — | US | disclosed |